Skip to main content

Joan Genescà Ferrer

Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine.

Institutions of which they are part

Head of group
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

Joan Genescà Ferrer

Institutions of which they are part

Head of group
Liver Diseases
Vall Hebron Institut de Recerca
Hepatologia
General Hospital

Internal medicine doctor expert in hepatology. Special dedication to advanced liver disease, liver cirrhosis and portal hypertension. Interest in non-invasive methods for the diagnosis and control of liver disease, especially liver elastography. Both clinical and experimental research in animal models of liver disease, including therapeutic studies with nanomedicine.

Chief Liver Unit.
Clinical director of Digestive Diseases.
Professor of Medicine of the UAB.

Projects

Sol·licitud d'intensificació per a la dedicació en el projecte "Investigación traslacional en complicaciones de la cirrosis: del modelo experimental a la clínica y viceversa" (PI15/00066).

IP: Rafael Esteban Mur
Collaborators: Joan Genescà Ferrer
Funding agency: Instituto de Salud Carlos III
Funding: 18000
Reference: INT16/00109
Duration: 31/01/2017 - 31/12/2017

Efectos de la administración de albúmina en pacientes cirròticos con encefalopatia hepática

IP: Rafael Esteban Mur
Collaborators: Joan Genescà Ferrer
Funding agency: Instituto de Salud Carlos III
Funding: 30000
Reference: INT15/00040
Duration: 01/01/2016 - 31/12/2016

Investigación traslacional en complicaciones de la cirrosis: del modelo experimental a la clínica y viceversa

IP: Joan Genescà Ferrer
Collaborators: Immaculada Raurell Saborit, Macarena Simon-Talero Horga, Mònica Pons Delgado
Funding agency: Instituto de Salud Carlos III
Funding: 130075
Reference: PI15/00066
Duration: 01/01/2016 - 31/10/2019

Mecanismes de neuromodulació a la hipertensió portal: noves possibilitats terapèutiques en la cirrosi hepàtica

IP: Joan Genescà Ferrer
Collaborators: -
Funding agency: Fundació Institut de Recerca HUVH
Funding: 46800
Reference: PRED-VHIR-2015-06
Duration: 09/02/2016 - 08/02/2018

Related news

Preliminary study results confirm that the drug resmetirom reduces the presence of fat, inflammation, cell damage and fibrosis in the liver.

The European project, in which Vall d'Hebron participates, will favor personalized diagnosis and innovative therapeutic strategies in patients with the disease.

The research team used nanotechnology to deliver the drug directly to liver cells, which eliminated side effects without reducing effectiveness.

Related professionals

Jordi Gómez i Prat

Jordi Gómez i Prat

Infectious Diseases
Read more
Carlos Hobeich Naya

Carlos Hobeich Naya

Research technician
Transfusional Medicine
Read more
Hector García  Fernandez

Hector García Fernandez

Research technician
Molecular Medical Imaging
Read more
Laura Vidal Tarrason

Laura Vidal Tarrason

Biomedical Research in Cancer Stem Cells
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.